Response to ‘Procalcitonin is a biomarker for disease severity rather than bacterial coinfection in COVID-19’ by Heer et al.
Emergency Department, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium
Received 23 March 2022 Accepted 6 April 2022
Correspondence to Stefano Malinverni, MD, Emergency Department, Centre Hospitalier Universitaire Saint-Pierre, Université Libre de Bruxelles, Rue Haute 322, 1000 Brussels, Belgium, Tel: +32 2 535 5039; e-mail: [email protected]
留言 (0)